WHAT WE INVEST IN
High-potential private European medical companies
Aescap Venture typically invests in private European medical companies working on the diagnosis or treatment of human diseases.
Companies are judged on the following criteria: key personnel, uniqueness/patents, product/market combinations, time-to-market, and envisaged exit opportunity.
We invest in companies active in the most promising segments in the medical industry. Companies using technologies that are sufficiently mature to yield realistic product-opportunities as well as cashflow from licensing deals.